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Abstract
Background: We aimed to determine the prevalence of consumption of oral contraceptives (OCs) among
adolescents and young women living in Spain and to identify the factors associated with this consumption.
Methods: We performed a cross-sectional study on the consumption of OCs by women aged 15–30 years
residing in Spain. We used secondary individualized data from the 2006 (n = 2513) and 2012 (n = 1530)
Spanish National Health Surveys. The dependent variable was the use of OCs in the previous 2 weeks.
Independent variables included sociodemographic characteristics, comorbidity, lifestyle, and healthcare
resource utilization.
The prevalence of OC consumption was analysed by investigating the changes observed between 2006 and
2012. We used multivariate logistic regression to identify the independent factors associated with OC use in
each year.
Results: In 2006, 14.42 % of women reported using OCs; this percentage dropped to 10.21 % in 2012 (p < 0.
05). Multivariate analysis revealed an association between OC use and visits to the gynaecologist (AOR, 5.60
[95 % CI, 2.93–10.73] in 2006; and AOR, 3.55 [95 % CI, 1.30–9.73] in 2012), Pap smear tests (AOR, 1.8 [95 %
CI, 1.23–2.87] in 2006; and AOR, 2.42 [95 % CI, 1.30–4.51] in 2012), and smoking in 2006 (AOR, 1.42 [95 %
CI, 1.04–1.93]).
Conclusions: There was a significant decrease in OC use from 2006 to 2012 among adolescents and young
women living in Spain. In the present study, consumers of OCs were women who visited a gynaecologist
more often and complied more with preventive measures such as Pap smear testing. Also, women who
reported having used OCs were more likely to smoke than the rest of the study population, although the
smoking habit is a risk factor for thrombotic events in women who take OCs.
Plain english summary
The introduction of the oral contraceptive pill has
allowed women to exercise greater control over the
childbearing phase of their life. The objectives of the
present study are to describe, using the data drawn from
the 2006 and 2012 Spanish National Health Surveys
(SNHS), the prevalence of contraceptive methods and
identify factors associated with the use of contraception
by adolescents and young women resident in Spain. Our
study population comprised women aged 15 to 30. A
total of 4043 women were included: 2513 from the 2006
SNHS and 1530 from the 2012 SNHS. The interviews
were conducted between June 2006 and June 2007
(SNHS2006); and from July 2011 to June 2012
(SNHS2012). The surveys use multistage cluster sampling,
with proportional random selection of primary and
secondary sampling units (towns and sections, respectively),
and the final units (individuals) are selected by means of
random routes and sex- and age-based quotas.
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This study found a significant decrease in OC use
among adolescents and young women living in Spain
from 2006 to 2012. The decrease in consumption of
OCs in Spain has two possible explanations: first, the
decrease could be due to a change in the social percep-
tion of oral contraceptives in Spain in terms of family
planning policy, because the male condom is the first
choice, and second, the economic recession seems to
have affected some indicators of sexual and reproductive
health. The OC consumers in our study were women who
visited a gynaecologist more often and complied more
with preventive measures such as Pap smear testing. Also,
women who reported having used OCs were more likely
to smoke than the rest of the study population, although
the smoking habit is a risk factor for thrombotic events in
women who take OCs.
Article summary
Strengths
 The strengths of our study include its large
population-based sample size, a randomly selected
population, the use of a standardized survey, training
of the data collectors, and our ability to control for a
broad range of major covariates.
Limitation
 We used data from a cross-sectional survey,
we cannot determine cause and effect relationships
between the variables associated with OC use.
 The SNHSs, rather than identifying specific active
pharmaceutical ingredients, identify groups of
medicines for specific diseases or disorders.
Consequently, we do not know whether OCs are
COCs or whether they are progestin-only pills
(POPs, the Mini-Pill).
Background
Modern contraception is one of the great public health
achievements of the last century. The introduction of
the oral contraceptive (OC) pill has allowed women to
exercise greater control over the childbearing phase of
their life. Several studies show that OCs are the most
popular form of reversible contraception in developed
countries [1–4]. However, many teenage pregnancies are
unplanned and generate a significant societal cost and
potential individual risk [5]. Around the world, appro-
ximately 16 million girls aged 15 to 19 and some one
million girls under 15 give birth every year, and 85 % of
these pregnancies are unplanned [6]. Every year in Spain,
there are about 4000 term pregnancies in adolescents
under the age of 17 [7]. Investigations carried out on the
use of contraception among Spanish women show that
the male condom is the most common method, followed
by OCs [8, 9]. OCs in Spain are available with prescrip-
tion or as over-the-counter (OTC) products. Oral con-
traceptives are available to Spanish women age 15 and
older at pharmacies, and there is no age limit on the
availability of emergency contraception. Contraceptives
are reasonably priced and are partially subsidized. The
price has not changed in recent years.
These findings are reflected in the Sexual Attitude of
Females in Europe Survey, which reveals significant
differences between the low use of pills in Spain and the
high demand in other countries (Italy, UK, France,
Germany, Sweden, Denmark, Norway, the Czech Repub-
lic, Austria, Estonia, Latvia, Lithuania, and the Russian
Federation) [5, 10]. The Health Behaviour in School-
Aged Children Study 2009/2010 showed that, among
15-year-old Spanish adolescents, 8 % of girls and 3 %
of the respondents’ male partners reported using contra-
ceptive pills during their last intercourse [11]. However,
forthcoming social and legislative changes in the area of
sexual and reproductive health in Spain could have an
impact on the patterns of use of contraception among
adolescents and young women. An example of a policy
change, that has already been implemented, is the OTC
availability of the emergency contraception in Spanish
pharmacies since 2010.
In this context, we aimed to determine the prevalence
of OC consumption among adolescents and young
women living in Spain and to identify the factors asso-
ciated with this consumption. We also analysed how this
prevalence changed from 2006 to 2012.
Methods
We conducted a nationwide, descriptive, cross-sectional
epidemiological study on the consumption of OCs by
adolescents and young women aged 15–30 years residing
in Spain. We used individualized secondary data from the
2006 and 2012 Spanish National Health Surveys (SNHS)
[12, 13]. SNHSs are interview-based surveys conducted by
the Ministry of Health in collaboration with the National
Statistics Institute (Instituto Nacional de Estadística) that
target a large sample of the non-institutionalized Spanish
population. The surveys use multistage cluster sampling,
with proportional random selection of primary and sec-
ondary sampling units (towns and sections, respectively).
The final units (individuals) are selected by means of
random routes and sex- and age-based quotas. The 2006
survey included 29,478 adults of both sexes interviewed
between June 2006 and June 2007; the 2012 survey
included 20,007 persons interviewed from July 2011 to
June 2012. Details of SNHS methodology are described
elsewhere [12, 13]. The variables included in our study
were created on the basis of a series of identically worded
questions asked in the two surveys used. Information
Carrasco-Garrido et al. Reproductive Health  (2016) 13:122 Page 2 of 9
was collected by direct home-based computer-assisted
interviews. The persons interviewed responded to the
questionnaires. Surveyors were previously trained in basic
communication skills, related procedures and specific
training on the questionnaire to be used.
Our study population comprised women aged 15 to
30. A total of 4043 women were included: 2513 from the
2006 SNHS and 1530 from the 2012 SNHS.
The information to create the dependent variables was
obtained from the answers “yes” or “no” to the question
“In the last two weeks have you taken the contraceptive
pill?”. Respondents who answered “yes” were then asked
the question “Were they prescribed for you by a doctor?”
Those who answered yes to the first question, regardless
of the answer to the second one, were considered con-
sumers of OCs.
The independent variables were the primary sociode-
mographic characteristics of the population, namely, age,
nationality, marital status, occupational status, educational
level, total household monthly income in euros, and social
class. The categories for these variables are shown in
Table 1.
Self-rated health was analysed as a dichotomous vari-
able (very good/good vs. fair/poor/very poor).
Variables related to comorbid chronic illness were
also analysed. These were collected using the question
“Has the doctor told you that you suffer from one of
these diseases?” The list of diseases comprised arterial
hypertension, hypercholesterolemia, heart disease, and dia-
betes. Women who reported suffering from one or more
of these conditions were classified as “chronic sufferers”.
The presence of depression or anxiety (psychological
disorders) was assessed using the following questions: 1)
“Have you suffered from depression or anxiety in the last
12 months?” And for those who answered “yes” 2) “Has
your doctor confirmed the diagnosis?” Only women who
answered “yes” to both questions were considered to have
a psychological disorder.
The lifestyle-related variables used in the study were
as follows: currently smoking (yes/no), consumption of
alcoholic beverages in the 2 weeks prior to the survey
(yes/no), leisure time physical activity (intense or mode-
rate vs. none), and self-reported body mass index (calcu-
lated from self-reported height and weight) categorized
as <25, 25–30 and >30.
In order to assess the use of healthcare resources,
subjects were asked about the following: i) visits to their
general practitioner in the last 12 months, ii) type of
health insurance (public vs. private), iii) visits to the
gynaecologist in the last 12 months, iv) Pap smear test
in the last 12 months, v) use of family planning services,
vi) consumption of any type of medication in the last
two weeks, and vii) use of any alternative medicine in
the last two weeks.
Statistical analysis
We calculated the prevalence of total consumption of
OCs for each of the two surveys and according to the
study variables. For the bivariate comparison of propor-
tions, Pearson’s χ2 or Fisher’s exact test was applied,
with values of p < 0.05 taken as significant. To estimate
the independent effect of OC use on study variables, we
also obtained the corresponding adjusted odds ratio
(AOR) through multivariate logistic regression analysis.
All variables that showed a significant association (p <
0.05) in the bivariate analysis were included in the multi-
variate analysis, along with variables that were consi-
dered relevant in the scientific literature.
Finally, to assess the time trend in the consumption
of OCs during the study period, we combined the respec-
tive databases of the two SNHS and calculated the crude
and adjusted odds ratios for having consumed OCs in
2012 compared with 2006. To calculate the AOR, all
variables that proved to be predictive in either SNHS
were included in the multivariate logistic regression.
Estimates were made using the svy (survey commands)
functions of the Stata program (STATA Corp, College
Station, Texas, USA), which enabled us to incorporate
the sampling design and weights into all of the statistical
calculations (descriptive, χ2, logistic regression). Statis-
tical significance was established as a two-tailed α < 0.05.
Table 1 Sociodemographic characteristic of the study





Age 15–22 827 (32.91) 612 (40)
23–30 1686 (67.09) 918 (60)
Nationality Immigrants 394 (15.68) 205 (13.40)
Spanish 2119 (84.32) 1325 (86.60)
Marital status Not married 1821 (72.46) 1278 (83.58)
Married 692 (27.54) 251 (16.42)
Occupational status Employed 1355 (53.92) 605 (39.54)
Unemployed 313 (12.46) 264 (17.25)
Inactive 845 (33.63) 661 (43.20)
Educational level Junior school 382 (15.56) 669 (43.72)
High school 1523 (62.04) 567 (37.06)
University and
higher education
550 (22.4) 294 (19.22)
Monthly income ≤1200 euros 842 (33.77) 536 (35.61)
> 1200 euros 1651 (66.23) 969 (64.39)
Social class High 317 (16.52) 249 (16.93)
Middle 667 (34.76) 472 (32.09)
Low 935 (48.72) 750 (50.99)
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Results
The study was based on data from 4043 women (2513
from the 2006 SNHS and 1530 from the 2012 SNHS)
aged 15–30 residing in Spain who answered the question
on consumption of OCs in the two weeks immediately
preceding the survey. Descriptions of the sociodemo-
graphic characteristics of the study population are shown
in Table 1.
The 2006 SNHS data revealed that 14.42 % (95 % CI,
12.75–16.27) of adolescents and young women residing
in Spain reported having taken the contraceptive pill in
the two weeks leading up to the survey. This proportion
decreased to 10.21 % (95 % CI, 8.61–12.07) in 2012, and
the crude difference proved statistically significant asso-
ciation (p < 0.05). Consumption was almost entirely by
prescription, with the percentages of self-medication being
only 5.90 % (95 % CI, 3.26–10.44) in 2006 and 4.84 %
(95 % CI, 2.44–9.35) in 2012.
Table 2 shows data on the prevalence of consumption
of OCs according to the sociodemographic characteris-
tics of the population and lifestyle variables. The biva-
riate analysis revealed that the prevalence of OC use was
highest in women aged 23 to 30 years during the study
period (17.375 in 2006 and 13.32 % in 2012), p < 0.05.
It is noteworthy that the frequency of OC consumption
was higher for university-educated women, women with
higher incomes, and smokers, a finding that was repeated
to a significant degree in both surveys (p < 0.05). Identical
results were obtained for alcohol consumption.
Table 3 shows the consumption of OCs as reported by
study participants and according to comorbid conditions
and use of healthcare resources. In 2006, OC consumption
Table 2 Prevalence of oral contraceptive use in adolescents and young women living in Spain, according to socio-demographic
variables and lifestyle. Spanish National Health Surveys 2006 and 2012
Oral contraceptive use
SNHS 2006 % (95 % CI) SNHS 2012 % (95 % CI)
Age*† 15–22 9.71 (7.47–12.52) 5.93 (4.33–8.07)
23–30 17.37 (15.12–19.87) 13.32 (10.91–16.17)
Nationality Immigrants 14.63 (10.58–19.87) 8.96 (5.21–14.96)
Spanish 14.37 (12.60–16.35) 10.52 (8.83–12.47)
Marital status Not married 13.77 (11.90–15.89) 9.87 (8.24–11.79)
Married 16.61 (13.19–20.71) 12.03 (7.52–18.71)
Occupational status*† Employed 18.45 (15.84–21.37) 13.28 (10.53–16.62)
Unemployed 11.91 (8.37–16.67) 9.22 (6.16–13.58)
Inactive 9.70 (7.53–12.42) 8.08 (5.91–10.94)
Educational level*† Junior school 11.00 (7.75–15.38) 7.69 (5.55–10.57)
High school 14.09 (12.00–16.47) 10.83 (8.41–13.82)
University and higher education 18.16 (14.35–22.72) 15.08 (10.93–20.44)
Monthly income† ≤ 1200 euros 12.89 (10.09–16.34) 7.75 (5.64–10.57)
> 1200 euros 15.36 (13.32–17.66) 11.34 (9.25–13.83)
Social Class High 19.14 (13.82–25.67) 11.40 (7.76–16.45)
Middle 15.72 (12.29–18.77) 11.70 (8.90–15.23)
Low 14.03 (11.11–17.45) 8.87 (6.74–11.57)
Smoking habit*† Non smoker 12.04 (10.21–14.15) 8.98 (7.19–11.15)
Smoker 19.11 (15.89–22.81) 13.24 (10.15–17.11)
Alcohol consumption* No 11.38 (8.86–14.49) 9.90 (8.12–12.03)
Yes 15.92 (13.82–18.28) 11.37 (8.14–15.68)
Physical activity Moderate 15.33 (13.08–17.89) 11.10 (8.90–13.76)
inactive 13.30 (10.92–16.11) 9.87 (7.56–12.80)
Body Mass Index Kg/sq.m < 25 14.19 (12.28–16.35) 11.31 (9.35–13.63)
25–29 16.91 (12.72–22.14) 6.52 (3.96–10.58)
30 or over 16.30 (9.02–27.65) 9.18 (4.15–19.11)
Total consumption of OCs 14.42 (12.75–16.27) 10.21 (8.61–12.07)
*Statistically significant association of consumption in SNHS 2006 (p < 0.05)
†Statistically significant association of consumption in SNHS 2012 (p < 0.05)
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was greater among adolescents and young women with
psychological disorders (19.16 %, p < 0.05). Both surveys
also showed that consumption was more common among
those who had made at least one visit to a gynecologist in
the past year than among those who had not. In addition,
the Pap smear test was more prevalent among women
using the pill (28.42 % vs. 7.19 % in 2006 and 15.96 % vs.
3.69 % in 2012) p < 0.05 and women using family planning
services.
The multivariate logistic regression analysis showed
the effect of each of the study variables, duly adjusted
for the remainder, on the overall consumption of OCs in
the study sample. These estimates were made for both
surveys and are shown in Table 4.
In 2006, the variables that were independently and
significantly associated with a higher likelihood of OC
use were smoking (AOR 1.42; 95%CI 1.04–1.93), p =
0.020, visits to the gynaecologist in the preceding
12 months (AOR, 5.6; 95 % CI, 2.93–10.73), p = 0.000,
having a Pap smear test (AOR 1.85; 95%CI, 1.23–2.87),
p = 0.003, and visiting family planning services (AOR,
3.56; 95 % CI, 2.14–5.93), p = 0.000.
In 2012, some of the predictive variables were the same
as in 2006, such as visits to the gynaecologist (AOR 3.55;
95 % CI, 1.30–9.73), p = 0.022, Pap smear tests (AOR 2.42;
95 % CI 1.30–4.51), p = 0.004, although a new variable,
use of alternative medicines (AOR, 2.83; 95 % CI,
1.32–6.04), p = 0.008, was also assessed.
The adjusted OR for having consumed OCs in 2012
with respect to 2006 was 0.67 (95 % CI, 0.52–0.85),
p = 0000. Therefore, after controlling for possible con-
founders, the likelihood of having consumed OCs in
2012 was lower than it had been 6 years previously.
Discussion
National health surveys have become a valid and widely
used research tool for ascertaining patterns of OC use
in the female population [14–17]. According to data
from a recent report with updated information on the
sexual behaviour of adolescents and the use of contracep-
tion, the hormonal contraceptive method most commonly
used by adolescents is the combined oral contraceptive
(COC) (55.6 % of young women have used an OC)
[18]. Recent studies on the development of OCs over
time show that this method has become increasingly
common among Spanish women [15, 19, 20]. Use of
hormonal contraception is mainly among women aged
20 to 30 [5, 9].
Table 3 Prevalence of oral contraceptive use in adolescents and young women living in Spain, according to comorbidity and use of
healthcare resources. Spanish National Health Surveys 2006 and 2012
Oral contraceptive use
SNHS 2006 % (95 % CI) SNHS 2012 % (95 % CI)
Self-assessment of health status Very good / Good 13.75 (11.91–15.82) 10.14 (8.45–12.12)
Fair / Poor / Very poor 17.30 (13.58–21.78) 10.81 (6.65–17.10)
Chronic illness* No 13.56 (11.77–15.46) 9.76 (8.08–11.74)
Yes 19.78 (14.96–25.68) 13.47 (9.02–19.63)
Psychological disorders* No 14.03 (12.31–15.96) 10.04 (8.40–11.97)
Yes 19.16 (13.33–26.76) 13.25 (7.45–22.46)
Medical consultation* No 12.40 (10.59–14.47) 9.75 (7.86–12.05)
Yes 18.48 (15.20–22.29) 11.25 (8.52–14.70)
Type of health insurance coverage Private 14.78 (8.39–24.72) 14.12 (9.71–20.08)
Public 14.41 (12.69–16.31) 9.61 (7.94–11.60)
Gynecologist visits in preceding 12 months*† No 2.27 (1.37–3.74) 1.95 (0.9–4.17)
Yes 20.09 (17.76–22.64) 13.86 (11.66–16.40)
Pap smear in preceding 12 months*† No 7.19 (5.43–9.48) 3.69 (2.38–5.68)
Yes 22.48 (19.74–25.49) 15.96 (13.32–19.00)
Family planning services in preceding 12 months*† No 12.85 (11.25–14.64) 9.81 (8.23–11.67)
Yes 41.78 (31.12–53.27) 19.39 (10.05–34.11)
Medication consumption*† No 14.24 (12.49–16.18) 9.46 (7.90–11.28)
Yes 16.46 (11.30–23.35) 19.93 (12.01–31.23)
Alternative medicines*† No 14.11 (12.42–15.99) 9.66 (8.07–11.53)
Yes 23.09 (14.32–35.02) 28.39 (16.44–44.40)
*Statistically significant association of consumption in SNHS 2006 (p < 0.05)
†Statistically significant association of consumption in SNHS 2012 (p < 0.05)
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However, the present study revealed a significant
decrease in the consumption of OCs during the study
period 2006–2012 (AOR, 0.67; 95 % CI, 0.52–0.85),
which is consistent with the results of a recent study by
Zelić-Kerep et al. [21], who quantified and analysed trends
in the use of oral hormonal contraceptives in the city of
Zagreb, Croatia. Their results showed a 76 % decrease in
the use of hormonal contraceptives from 2008 to 2009.
In the 2012, the prevalence of OC use reached 10.21 %
among adolescents and young women living in Spain.
This percentage was considerably lower than the 16.2 %
found by Cea-Soriano et al. [22] in a study to determine
prescription contraceptive use in the United Kingdom
with data from The Health Improvement Network
(THIN). Løkkegaard [23] also showed higher percent-
ages of OC use among Danish female adolescents. By
age 17, more than 50 % of Danish female adolescents
had had a prescription for hormonal contraceptives.
Similarly, a recent study showed that, among Portuguese
adolescents, 33 % of girls and 18 % of the respondents’
male partners had used contraceptive pills during their
most recent intercourse [11].
The decrease in consumption of OCs in Spain has
two possible explanations. First, different investigations
conducted in Spain on the use of contraceptive methods
among the female Spanish population indicate that
condoms are the method most used in our country. The
rate of condom use in Spain is relatively high (71 %) in
adolescents and young adults [8] in comparison with
other European countries, such as Greece (53.87 %) [24]
and Sweden (68 %) [25]. Many investigations highlight the
fact that the use of condoms in the Spanish population
has not decreased; on the contrary, it continues to increase
in percentage terms (38.8 % in 2007 to 46.7 % in 2012).
Second, the economic recession seems to have affected
some indicators of sexual and reproductive health. Since
the beginning of the recession, contraceptive use has
declined [26], and access to contraception has become
difficult because of cost [27]. In this sense, if our National
Health system continues to stop funding new-generation
OCs, which are more efficient and safer, new barriers to
their distribution would appear [28]. Therefore, young
Spanish women would choose other contraceptive
methods. In addition, since 2010, the emergency contra-
ception has been sold directly in Spanish pharmacies
without the need for a medical prescription. It is possible
that when women were provided EC without a prescrip-
tion, they were more likely to use the method [29, 30].
The association between copayment and hormonal
contraception was analysed by Kazerooni et al. [31] and
Poncet et al. [32], whose results show the relationship
between socioeconomic status and the use and method
of contraception among women residents in France.
OCs remain an effective form of contraception, despite
the availability of newer methods such as intrauterine
devices or the extended-cycle pill. Generic and OTC
contraceptives are favored by third-party payers. As a
result, potentially exciting developments in the safety of
branded oral contraceptives may have gone unnoticed
[33]. However, Foster et al. [34], showed that the interest
in OTC access to oral contraceptives is high. If out-of-
pocket costs for such pills are low, OTC access could
have a significant effect on the use of effective contracep-
tives and unintended pregnancy. In this sense, cost will
continue to determine whether these new contraceptive
methods are accepted, unless substantial health benefits
Table 4 Factors associated with consumption of oral contraceptives in adolescents and young women living in Spain. Spanish
National Health Surveys 2006–2012
Variables SNHS 2006 SNHS 2012
Adjusted OR 95 % CI p-value Adjusted OR 95 % CI p-value
Age 15–22 1 1
23–30 0.92 (0.61–1.36) 0.867 1.29 (0.80–2.05) 0.257
Smoking habit Non smoker 1 1
Smoker 1.42 (1.04–1.93) 0.020 NS 0.547
Gynecologist visits in preceding 12 month No 1 1
Yes 5.60 (2.93–10.73) 0.000 3.55 (1.30–9.73) 0.022
Pap smear test in preceding 12 months No 1 1
Yes 1.87 (1.23–2.87) 0.003 2.42 (1.30–4.51) 0.004
Family planning services in preceding 12 months No 1 1
Yes 3.56 (2.14–5.93) 0.000 NS 0.147
Alternative medicines No 1 1
Yes NS 0.851 2.83 (1.32–6.04) 0.008
Data are expressed as adjusted odds ratio (AOR) and 95 % confidence intervals (95 % CI)
NS non-significant association
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can be adequately proven. The economic recession may
have played a role in this decrease.
A lifestyle analysis revealed that, in 2006, women who
reported having used OCs were more likely to smoke
than the rest of the study population (AOR, 1.42; 95 %
CI, 1.04–1.93). Several studies have reported that OCs
and smoking-derived nicotine are known to synergisti-
cally increase the risk and severity of cerebral ischemia
in women [35]. COC users who are current smokers
have a tenfold higher risk of myocardial infarction and
an almost threefold risk of stroke than those who do not
[36]. The study by Berlín et al. in France [37] showed
that hormonal contraception in adolescent girls can
accelerate the metabolism of cotinine. The increased rates
of smoking among teenagers are not unique of Spain.
Adolescents start smoking in response to social influences,
emulating the behavior of friends and family members,
and are influenced by the media. There is a possible rela-
tion between smoking and early sexual initiation. Recent
studies show that the smoking prevalence is higher among
disadvantaged groups [38], and also that girls with low
educational and socioeconomic status tend to experience
sex at a younger age. This situation is a window of oppor-
tunity to promote hormonal contraception [39]. Interven-
tions targeting young women should be developed to
increase their knowledge about contraceptive methods
and the risk of smoking.
As for preventive measures, our results show that
during the study period, OC users were more likely to
have a Pap smear test than women who did not use OCs.
We must also bear in mind that the International Agency
for Research on Cancer (IARC) has classified COCs as
carcinogenic for humans. Therefore, regular smear tests in
sexually active women can be considered the best method
for the prevention of cervical cancer.
As for healthcare resource–related variables, our results
revealed that the variable with the greatest strength of
association with OC use in both surveys was visits to the
gynaecologist in the previous 12 months (AOR, 5.60
[95 % CI, 2.93–10.73] in 2006 and AOR, 3.55 [95 % CI,
1.30–9.73] in 2012). Adolescents are a special group who
need motivational counselling and care to ensure that they
adhere to the daily routine and to continue regular use
[40, 41]. As a result, gynaecologists attempt to adapt
prescriptions to the specific characteristics of available
pills in order to improve adherence [42]. A working know-
ledge of contraception will assist the paediatrician and
gynaecologist in both promoting sexual health and treat-
ing common adolescent gynaecological problems.
Family planning services were also associated with
OC use. In 2006, young women who reported having
used OCs were more likely to visit family planning
services than women who did not (AOR, 3.56 [95 % CI,
2.14–5.93]). These results are consistent with those of
other studies on the utilization and perception of health
services, such as the REPROSTAT project (Reproductive
health indicators in the European Union), which
highlighted that only 31 % of the youths interviewed had
ever visited a health center to receive information on
contraception, pregnancy, abortion, and STIs [43]. In
the same line Darney et al. [44] in a study conducted
in Mexico, to determine associations between age and
patient-reported quality of family planning services among
adolescents and young women, showed that although
a lower proportion of adolescents reported long-acting
reversible contraception (LARC) use, in comparison with
young women, the adolescents using hormonal and LARC
had significantly lower odds of reporting high-quality
care compared with women aged 25–29. The role of
family planning services is essential because the evidence
supports that teenagers are more likely to choose a
LARC method and continue with that method if they
are offered [45].
Finally, in the 2012 SNHS, women who reported
having used OCs were more likely to use alternative
medicines than the rest of the study population
(AOR, 2.83 [95 % CI, 1.32–6.04]). It is known that
interactions between hormonal contraceptives and other
herb-drugs can reduce the efficacy of OCs [46]. In the
USA, Murphy et al. [47] evaluated the effect of the herbal
remedy St. John’s Wort on OCs and found that treatment
with St. John’s Wort was associated with a significant
13–15 % reduction in exposure to the OC.
The strengths of our study include its large population-
based sample size, a randomly selected population, the use
of a standardized survey, training of the data collectors,
and our ability to control for a broad range of major
covariates, including sociodemographic factors and vari-
ables associated with the use of health services. However,
our study is also subject to a number of possible limita-
tions. First, since we used data from a cross-sectional sur-
vey, we cannot determine cause and effect relationships
between the variables associated with OC use. Second, the
conclusions drawn are difficult to generalize, because the
survey has not been validated for the consumption of
medication. Third, information obtained from interviews
is subjective and may be subject to recall errors or the
tendency of subjects to give socially desirable responses.
Another possible limitation of SNHSs is that, rather than
identifying specific active pharmaceutical ingredients, they
identify groups of medicines for specific diseases or disor-
ders. Consequently, we do not know whether OCs are
COCs or whether they are progestin-only pills (POPs, the
Mini-Pill). Furthermore, the SNHS does not allow us to
differentiate between women who took emergency contra-
ceptives and women who had taken any kind of OC or
other method used beside OCs. In the same line, the
SNHS does not include data regarding LARCs use, among
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the population consulted, but other studies have found
that the use of LARC is very low in Spain [48] compared
with other countries, for example Mexico [44].
Finally, the SNHS does not include data about the
sexual behaviour or reproductive and contraceptive
knowledge of the population consulted. Finally, another
limitation is that younger women who still live at their
parents’ house because the they have not completed high
school/university and/or have not started working full
time, are affected by factors such as economic status and
parental education.
Lastly, given that the initial response rate to the 2006
SNHS was 65 % and the initial response rate to the 2012
SNHS was 61 %, a possible non-response bias must be
considered [12, 13]. According to the National Statistics
Institute (INE), the initial non-response rate in both
surveys was slightly higher among female, non-Spanish
subjects, and those in the 40–65 age groups [49, 50].
Conclusion
We observed a significant decrease in OC use among
adolescents and young women living in Spain from 2006
to 2012.
In the present study, consumers of OCs were women
who visited their gynaecologist often and followed
preventive measures such as Pap smear testing. Also,
women who reported having used OCs were more likely to
smoke than the rest of the study population, although the
smoking habit is a risk factor for thrombotic events in
women who take OCs.
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